SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-22-054707
Filing Date
2022-05-02
Accepted
2022-05-02 16:39:31
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2214133d3_10ka.htm   iXBRL 10-K/A 960107
2 EXHIBIT 31.1 tm2214133d3_ex31-1.htm EX-31.1 4014
3 EXHIBIT 31.2 tm2214133d3_ex31-2.htm EX-31.2 3917
7 GRAPHIC tm2214133d3_10kasp2img001.jpg GRAPHIC 120842
8 GRAPHIC tm2214133d3_10kasp2img002.jpg GRAPHIC 114866
  Complete submission text file 0001104659-22-054707.txt   1917465

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20211231.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20211231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20211231_pre.xml EX-101.PRE 23996
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2214133d3_10ka_htm.xml XML 5655
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36306 | Film No.: 22882610
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences